Sign in Create account

CCME GLOBAL LIMITED

Healthcare · Pharmaceuticals & Biotechnology

BSE: 514336
₹43.69
▼ -2.29 (-4.98%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
42/100
Moderate
Valuation
21/100
Expensive
Momentum
86/100
Bullish

QVM read Momentum-led Quality Moderate, Valuation Expensive, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹198 Cr
PE (TTM)
Data unavailable.
Price to Book
4.9
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
203.6
Free Cash Flow
₹5 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
33.33%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
-124.73%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
0.00%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
-123.73%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
53.40%
as of June 30, 2014
Industry median 14.05% (173 companies)
Current Ratio
8.64
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.00
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
0.78
as of Sept. 30, 2025
Industry median 10.58 (182 companies)
Net Margin
71.15%
as of March 31, 2019
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
-88.00%
as of March 31, 2009
Industry median 14.22% (181 companies)
Operating Margin (TTM)
-86.53%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
-1.58%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
-1.78%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
-1.78%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 6 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.00)
  • No Return on equity is 15% or more (-1.8%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

2 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 5 met
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-5.0%
Low 43.6900 · High 43.6900
1W return
4.5%
Low 41.9700 · High 50.8000
1M return
15.6%
Low 26.4100 · High 50.8000
52W return
203.6%
Low 26.4100 · High 89.6000
Lifetime High ₹89.6000 (Aug. 6, 2026)
Lifetime Low ₹2.0100 (June 21, 2012)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish5
Bearish1
5D
44.5
10D
42.3
20D
40.3
50D
36.2
100D
28.8
200D
16.4

Delivery and volume

Day avg. delivery
100.0%
Week avg. delivery
92.1%
Month avg. delivery
86.0%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

43.69
Pivot
First resistance43.69
Second resistance43.69
Third resistance43.69
First support43.69
Second support43.69
Third support43.69
Day RSI57.1
Day MFI73.1
Day MACD1.88
Day MACD signal0.48

Beta

1M0.35
3M-0.36
1Y-0.36
3Y0.93

Price change analysis

↑ 15.6%
Over 1 Month
LowHigh
26.4150.80
↑ 203.6%
Over 3 Months
LowHigh
26.4189.60
↑ 203.6%
Over 6 Months
LowHigh
26.4189.60
↑ 203.6%
Over 1 Year
LowHigh
26.4189.60
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹0 Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹-0.0600

Ranks #119 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter74.35%

Largest holders

NameCategoryShares %Shares
PADMANABAN KRISHNAMOORTHYPromoter62.0300%28070400
VENKATRAMAN VARALAKSHMIPromoter12.3100%5572300
VIDHUMOHAN PILLAIPublic4.4200%2000000
NOOR MUHAMMED HABIBULLAHPublic4.4200%2000000
SURESH KUMAR RAMANIPublic4.4200%2000000

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings increased from 74.17% to 74.35% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 12 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
28 Jun 2017 NAGA VENKATA TIRUMALA SRAVANI POTHURI Block Sell 1,228,000 4.1000 BSE
28 Jun 2017 AMARENDRA BUSSA Block Buy 1,228,000 4.1000 BSE
28 Jun 2017 AMARENDRA BUSSA Bulk Buy 1,228,000 4.1000 BSE
28 Jun 2017 NAGA VENKATA TIRUMALA SRAVANI POTHURI Bulk Sell 1,228,000 4.1000 BSE
14 Jun 2017 NAGA KANAKA DURGA PRASAD CHALAVADI Block Buy 628,000 4.1200 BSE
14 Jun 2017 SREEVANI VANKADARA Block Sell 628,000 4.1200 BSE
14 Jun 2017 SREEVANI VANKADARA Bulk Sell 628,000 4.1200 BSE
14 Jun 2017 NAGA KANAKA DURGA PRASAD CHALAVADI Bulk Buy 628,000 4.1200 BSE
7 Jun 2017 VENKATA RAJESH ANNAM Bulk Buy 225,000 4.1600 BSE
7 Jun 2017 CHANDRA MOHAN SUBHASH ANNAM Bulk Buy 225,000 4.1600 BSE

All bulk and block deals →

Corporate Actions

Full history (2 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from GENESIS IBRC INDIA LIMITED to CCME GLOBAL LIMITED
—NAME_CHANGEName changed from SSK Lifestyles Limited to GENESIS IBRC INDIA LIMITED

All corporate actions →

Corporate Announcements

All 14 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Company Update CCME Global Ltd - 514336 - Proceedings Of AGM Held On September 29, 2026.
29 Sep 2026 AGM/EGM CCME Global Ltd - 514336 - Proceedings Of AGM Held On September 29, 2026
29 Sep 2026 AGM/EGM CCME Global Ltd - 514336 - Shareholder Meeting / Postal Ballot-Outcome of AGM
29 Sep 2026 Company Update CCME Global Ltd - 514336 - Announcement under Regulation 30 (LODR)-Change in Management
29 Sep 2026 Company Update CCME Global Ltd - 514336 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
29 Sep 2026 AGM/EGM CCME Global Ltd - 514336 - Scrutinizer''s Report And Voting Results For The AGM Held On September 29, 2026
29 Sep 2026 AGM/EGM CCME Global Ltd - 514336 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
29 Sep 2026 Company Update CCME Global Ltd - 514336 - Announcement under Regulation 30 (LODR)-Change in Directorate
29 Sep 2026 Company Update CCME Global Ltd - 514336 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
29 Sep 2026 Company Update CCME Global Ltd - 514336 - Announcement under Regulation 30 (LODR)-Preferential Issue

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Strong net profit margin (71.2%)
  • Low financial leverage (Debt/Equity 0.00)
  • Strong revenue growth YoY (53.4%)

Weaknesses

  • Low Return on Equity (-1.8%)
  • Declining profit YoY (-123.7%)

Opportunities

Data unavailable.

Threats

  • Weak interest coverage (0.8x) -- limited cushion against rising rates

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about CCME GLOBAL LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.